Skip to content
← Back to this collection

PUBLICATIONS · 18506764

Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2008 Sep
First author
Leavey PJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Leavey PJ
      type
      Author
    2. name
      Mascarenhas L
      type
      Author
    3. name
      Marina N
      type
      Author
    4. name
      Chen Z
      type
      Author
    5. name
      Krailo M
      type
      Author
    6. name
      Miser J
      type
      Author
    7. name
      Brown K
      type
      Author
    8. name
      Tarbell N
      type
      Author
    9. name
      Bernstein ML
      type
      Author
    10. name
      Granowetter L
      type
      Author
    11. name
      Gebhardt M
      type
      Author
    12. name
      Grier HE
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Leavey PJ
      type
      Author
    2. name
      Mascarenhas L
      type
      Author
    3. name
      Marina N
      type
      Author
    4. name
      Chen Z
      type
      Author
    5. name
      Krailo M
      type
      Author
    6. name
      Miser J
      type
      Author
    7. name
      Brown K
      type
      Author
    8. name
      Tarbell N
      type
      Author
    9. name
      Bernstein ML
      type
      Author
    10. name
      Granowetter L
      type
      Author
    11. name
      Gebhardt M
      type
      Author
    12. name
      Grier HE
      type
      Author
    bibliography ids
    1. nci-bib-72cae35a285686c30ddf10d9
    book metadata
    content sha256
    98fb75fa8d7aa0aee3d7041e64d94e7f26c3532d2d89fc2592ea0e79309a38b3
    document type
    citation
    dois
    1. 10.1002/pbc.21618
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:18506764
    immutable id
    pubmed:18506764@98fb75fa8d7aa0aee3d7041e64d94e7f26c3532d2d89fc2592ea0e79309a38b3
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    3
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    334-8
    volume
    51
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      18506764
      provenance
      batch id
      e663b4be92ee60a9b059
      provider
      NCBI PubMed ESummary
      record sha256
      57317f6fc309f8b551be6c277c93eb4da1d058747b5d36ab6e795012efb0d5df
      response sha256
      514286e846d1566a3f75c88a4af66b82adfc16ee2368b19bce657f2237aba90d
      retrieved at
      2026-09-09T23:46:19.265979+00:00
      publication date
      display
      2008 Sep
      precision
      month
      year
      2008
      publication types
      1. Journal Article
      2. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/18506764/
      title
      Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology Group.

      Preserved source evidence · Not medical advice